Clinical Trials on Advanced Neoplasia in New Zealand
Total 16888 results
-
Neovii BiotechFresenius Biotech North AmericaTerminatedAdvanced Breast Cancer | Metastatic Breast CancerUnited States, Canada
-
AlexionAchillion, a wholly owned subsidiary of AlexionCompletedParoxysmal Nocturnal HemoglobinuriaNew Zealand, Korea, Republic of, Italy
-
Regeneron PharmaceuticalsRecruiting
-
Roswell Park Cancer InstituteNovartisCompletedAdvanced Malignant Solid Neoplasm | Metastatic Pancreatic Adenocarcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | ALK PositiveUnited States
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLCCompletedAdvanced Solid TumorsUnited States, Korea, Republic of, Canada, Taiwan
-
Leap Therapeutics, Inc.Pfizer; Merck KGaA, Darmstadt, GermanyTerminatedSolid Tumors | Advanced Triple Negative Breast Cancer | Advanced Hormone Receptor Positive/Endocrine Refractory Breast Cancer | Advanced Metastatic Castration-Resistant Prostate Cancer | Advanced Platinum-Resistant Ovarian CancerUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorUnited States
-
Hoosier Cancer Research NetworkUniversity of Sydney; Bionomics Limited; Australia New Zealand Gynaecological...WithdrawnOvarian CancerUnited States, Australia, New Zealand
-
AstraZenecaSyneos HealthCompletedAdvanced Solid TumoursUnited States, Spain, Korea, Republic of, United Kingdom
-
Zimmer BiometCompleted
-
Bristol-Myers SquibbCompletedAdvanced CancerUnited States, Belgium, Canada
-
Zhejiang Medicine Co., Ltd.Ambrx, Inc.TerminatedStomach Neoplasms | Breast NeoplasmsAustralia, New Zealand
-
Acceleron Pharma Inc. (a wholly owned subsidiary...CompletedAdvanced Adult Hepatocellular CarcinomaUnited States
-
Alessa Therapeutics Inc.CompletedLower Urinary Tract Symptoms | Prostate AdenocarcinomaUnited States, Australia, New Zealand
-
Bristol-Myers SquibbCompletedAdvanced CancerUnited States, Canada, Italy, Netherlands, Spain, Israel
-
Canadian Cancer Trials GroupBristol-Myers Squibb; Cancer Research Institute, New York City; Personal Genome...TerminatedAdvanced Solid TumorsUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterUniversity of Chicago; Genentech, Inc.; Ohio State University; TargosActive, not recruitingUrothelial Carcinoma | Locally Advanced | UnresectableUnited States
-
Zealand University HospitalRecruitingNon-small Cell Lung Cancer MetastaticDenmark
-
Institut de Recherches Internationales ServierTerminatedLymphoma | Advanced Solid TumorsUnited States, Spain, France
-
Repare TherapeuticsRoche Pharma AGRecruitingAdvanced Solid Tumor, AdultUnited States
-
Coegin Pharma ABBispebjerg Hospital; Studies&MeActive, not recruiting
-
Slagelse HospitalZealand University Hospital; Association of Danish PhysiotherapistsWithdrawnQuality of Life | Low Anterior Resection Syndrome | Rectum Cancer | Faecal IncontinenceDenmark
-
Bristol-Myers SquibbCompletedAdvanced MelanomaUnited States, United Kingdom
-
Trans Tasman Radiation Oncology GroupCompletedBladder CancerAustralia, New Zealand
-
Apellis Pharmaceuticals, Inc.CompletedParoxysmal Nocturnal HemoglobinuriaHong Kong, Thailand, New Zealand, Malaysia
-
Fujifilm Pharmaceuticals U.S.A., Inc.RecruitingAdvanced Solid TumorsUnited States
-
Merck Sharp & Dohme LLCRecruitingAdvanced Solid Tumors | Metastatic Solid TumorsCanada, Switzerland, United States
-
Aulos Bioscience, Inc.RecruitingMetastatic Cancer | Advanced Solid TumorAustralia, United States
-
Kartos Therapeutics, Inc.CompletedCancer | Glioblastoma | Multiple Myeloma | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States, France, Netherlands
-
University of Rochester NCORP Research BaseNational Cancer Institute (NCI); University of Alabama at BirminghamEnrolling by invitationAdvanced Solid TumorUnited States
-
New Mexico Cancer Care AllianceTerminatedAdvanced CancerUnited States
-
PfizerTerminatedAdvanced Breast CancerUnited States, Hungary, Spain, Belgium, China, Hong Kong, Australia, Poland, Canada, India, South Africa
-
NRG OncologyNational Cancer Institute (NCI)RecruitingAdvanced Head and Neck Squamous Cell Carcinoma | Squamous Cell Carcinoma of Unknown Primary | Advanced Hypopharyngeal Squamous Cell Carcinoma | Advanced Laryngeal Squamous Cell Carcinoma | Advanced Oropharyngeal Squamous Cell CarcinomaUnited States, Canada
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited States, Germany, Italy, United Kingdom, Canada, France, Korea, Republic of, Netherlands
-
Irene WesselRigshospitalet, Denmark; Danish Cancer Society; Danish Association of Occupational... and other collaboratorsCompleted
-
Bristol-Myers SquibbTerminated
-
Hellenic Cooperative Oncology GroupAmgenTerminatedAdvanced Colorectal CancerGreece, Cyprus
-
Dartmouth-Hitchcock Medical CenterNational Institute on Aging (NIA); Sound PhysiciansCompletedAdvance Care PlanningUnited States
-
Dartmouth-Hitchcock Medical CenterNational Institute on Aging (NIA); Sound PhysiciansTerminatedAdvance Care PlanningUnited States
-
OncoTherapy Science, Inc.TerminatedAML | Advanced MDS | ALL | Advanced CML | Advanced MPNsUnited States
-
Icahn School of Medicine at Mount SinaiActive, not recruitingLocally Advanced HPV Positive Oropharynx CancerUnited States
-
Bristol-Myers SquibbActive, not recruitingAdvanced CancerUnited States, Australia, Canada, Japan
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, Australia
-
AmgenActive, not recruitingKRAS p.G12C Mutant Advanced Solid TumorsUnited States, France, Canada, Spain, Belgium, Korea, Republic of, Austria, Australia, Hungary, Greece, Germany, Japan, Romania, Switzerland, Brazil, Portugal
-
Hoffmann-La RocheTerminatedAdvanced/Metastatic Head and Neck, Oesophageal and Cervical CancersKorea, Republic of, France, Spain, Belgium, United Kingdom, Singapore, Israel, Russian Federation, Taiwan, Switzerland, Turkey, United States, New Zealand, Poland, Germany
-
Novartis PharmaceuticalsCompletedCancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological MalignanciesUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors With Alterations of FGFR1, 2 and or 3 | Squamous Lung Cancer With FGFR1 Amplification | Bladder Cancer With FGFR3 Mutation or Fusion | Advanced Solid Tumors With FGFR1 Amplication | Advanced Solid Tumors With FGFR2 Amplication | Advanced Solid Tumors With FGFR3 MutationFrance, Spain, Taiwan, Germany, Netherlands, Singapore, United States, Australia, Korea, Republic of, Thailand, Israel, Italy, Turkey, Austria
-
Incyte CorporationRecruitingA Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid TumorsAdvanced Solid Tumors | Solid Tumors | Metastatic Solid TumorsUnited States, Spain, United Kingdom, France, Italy, Denmark, Switzerland
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors | Recurrent or Refractory Medulloblastoma | Locally Advanced or Metastatic Basal Cell CarcinomaUnited States, United Kingdom, Switzerland, Netherlands
-
Concord Repatriation General HospitalRecruitingHCC | Hepatocellular CarcinomaAustralia, New Zealand